| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| SECT-B.ST - | HOLD | 0 @ 20.2492 | 0 | |
| GRF.MC - Grifols SA | HOLD | 0 @ 9.38 | 0 | |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ 17.6898 | 0 | |
| GXI.DE - Gerresheimer AG | HOLD | 0 @ 79.45 | 0 | |
| AFX.DE - Carl Zeiss Meditec AG | HOLD | 0 @ 60.6 | 0 | |
| HLN.L - Haleon PLC | HOLD | 0 @ 4.62191 | 0 | |
| IPN.PA - Ipsen SA | HOLD | 0 @ 111.6 | 0 | |
| LONN.SW - | HOLD | 0 @ 559.255 | 0 | |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ 53.92 | 0 | |
| QIA.DE - QIAGEN NV | HOLD | 0 @ 36.2 | 0 | |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ 53 | 0 | |
| SDZ.SW - | HOLD | 0 @ 38.7081 | 0 | |
| HIK.L - | HOLD | 0 @ 24.5996 | 0 | |
| SFZN.SW - | HOLD | 0 @ 929.326 | 0 | |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ 52.46 | 0 | |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ 13.0121 | 0 | |
| SOBI.ST - | HOLD | 0 @ 25.5175 | 0 | |
| SOON.SW - | HOLD | 0 @ 284.087 | 0 | |
| SRT3.DE - Sartorius AG | HOLD | 0 @ 239.9 | 0 | |
| STMN.SW - | HOLD | 0 @ 118.292 | 0 | |
| TECN.SW - | HOLD | 0 @ 185.139 | 0 | |
| TUB.BR - Financiere de Tubize SA | HOLD | 0 @ 137.2 | 0 | |
| ZEAL.CO - | HOLD | 0 @ 90.3605 | 0 | |
| DEMANT.CO - | HOLD | 0 @ 33.8919 | 0 | |
| ALC.SW - | HOLD | 0 @ 81.399 | 0 | |
| ALK-B.CO - | HOLD | 0 @ 18.4609 | 0 | |
| AMBU-B.CO - | HOLD | 0 @ 16.1281 | 0 | |
| AMP.MI - Amplifon SpA | HOLD | 0 @ 20.32 | 0 | |
| ARGX.BR - Argenx SE | HOLD | 0 @ 540.8 | 0 | |
| BANB.SW - | HOLD | 0 @ 54.6602 | 0 | |
| BAVA.CO - | HOLD | 0 @ 22.2214 | 0 | |
| BAYN.DE - Bayer AG | HOLD | 0 @ 23 | 0 | |
| BIM.PA - BioMerieux | HOLD | 0 @ 111.8 | 0 | |
| CTEC.L - ConvaTec Group PLC | HOLD | 0 @ 3.08919 | 0 | |
| GMAB.CO - | HOLD | 0 @ 184.006 | 0 | |
| DIA.MI - DiaSorin SpA | HOLD | 0 @ 98.86 | 0 | |
| EKTA-B.ST - | HOLD | 0 @ 5.16816 | 0 | |
| GETI-B.ST - | HOLD | 0 @ 19.3886 | 0 | |
| GALD.SW - | HOLD | 0 @ 95.6293 | 0 | |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ 39.44 | 0 | |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ 44.56 | 0 | |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ 50.04 | 0 | |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ 270 | 0 | |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ 194.8 | 0 | |
| SAN.PA - Sanofi SA | SELL | -179 @ 105.94 | -18,963 | The ETF sold 179 shares of SAN.PA on 2025-03-12. The shares were previously bought for an average price of 104.5. The Sanofi SA shares were sold for 1.4% higher than average price of previous purchases. This sale made a profit of 258 The average price that the ETF previously sold SAN.PA share for is so the ETF has sold 179 shares on 2025-03-12 at a higher price than the previous selling average. |
| COLO-B.CO - | SELL | -196 @ 97.8949 | -19,187 | The ETF sold 196 shares of COLO-B.CO on 2025-03-12. The shares were previously bought for an average price of 106.533. The shares were sold for -8.1% lower than average price of previous purchases. This resulted in an overall loss of 1,693 The average price that the ETF previously sold COLO-B.CO share for is so the ETF has sold 196 shares on 2025-03-12 at a higher price than the previous selling average. |
| MRK.DE - Merck KGaA | SELL | -143 @ 134.25 | -19,198 | The ETF sold 143 shares of MRK.DE on 2025-03-12. The shares were previously bought for an average price of 134.5. The Merck KGaA shares were sold for -0.2% lower than average price of previous purchases. This resulted in an overall loss of 36 The average price that the ETF previously sold MRK.DE share for is so the ETF has sold 143 shares on 2025-03-12 at a higher price than the previous selling average. |
| PHIA.AS - Koninklijke Philips NV | SELL | -790 @ 24.52 | -19,371 | The ETF sold 790 shares of PHIA.AS on 2025-03-12. The shares were previously bought for an average price of 26.99. The Koninklijke Philips NV shares were sold for -9.2% lower than average price of previous purchases. This resulted in an overall loss of 1,951 The average price that the ETF previously sold PHIA.AS share for is so the ETF has sold 790 shares on 2025-03-12 at a higher price than the previous selling average. |
| NSIS-B.CO - | SELL | -359 @ 54.8464 | -19,690 | The ETF sold 359 shares of NSIS-B.CO on 2025-03-12. The shares were previously bought for an average price of 54.5668. The shares were sold for 0.5% higher than average price of previous purchases. This sale made a profit of 100 The average price that the ETF previously sold NSIS-B.CO share for is so the ETF has sold 359 shares on 2025-03-12 at a higher price than the previous selling average. |
| UCB.BR - UCB SA | SELL | -129 @ 181 | -23,349 | The ETF sold 129 shares of UCB.BR on 2025-03-12. The shares were previously bought for an average price of 190.35. The UCB SA shares were sold for -4.9% lower than average price of previous purchases. This resulted in an overall loss of 1,206 The average price that the ETF previously sold UCB.BR share for is so the ETF has sold 129 shares on 2025-03-12 at a higher price than the previous selling average. |
| NOVN.SW - | SELL | -311 @ 99.8922 | -31,066 | The ETF sold 311 shares of NOVN.SW on 2025-03-12. The shares were previously bought for an average price of 103.212. The shares were sold for -3.2% lower than average price of previous purchases. This resulted in an overall loss of 1,032 The average price that the ETF previously sold NOVN.SW share for is so the ETF has sold 311 shares on 2025-03-12 at a higher price than the previous selling average. |
| AZN.L - AstraZeneca PLC | SELL | -242 @ 138.313 | -33,472 | The ETF sold 242 shares of AZN.L on 2025-03-12. The shares were previously bought for an average price of 141.451. The AstraZeneca PLC shares were sold for -2.2% lower than average price of previous purchases. This resulted in an overall loss of 759 The average price that the ETF previously sold AZN.L share for is so the ETF has sold 242 shares on 2025-03-12 at a higher price than the previous selling average. |
| NOVO-B.CO - Novo Nordisk A/S | SELL | -508 @ 68.0519 | -34,570 | The ETF sold 508 shares of NOVO-B.CO on 2025-03-12. The shares were previously bought for an average price of 78.5252. The Novo Nordisk A/S shares were sold for -13.3% lower than average price of previous purchases. This resulted in an overall loss of 5,320 The average price that the ETF previously sold NOVO-B.CO share for is so the ETF has sold 508 shares on 2025-03-12 at a higher price than the previous selling average. |
| ROG.SW - | SELL | -112 @ 318.73 | -35,698 | The ETF sold 112 shares of ROG.SW on 2025-03-12. The shares were previously bought for an average price of 307.841. The shares were sold for 3.5% higher than average price of previous purchases. This sale made a profit of 1,220 The average price that the ETF previously sold ROG.SW share for is so the ETF has sold 112 shares on 2025-03-12 at a higher price than the previous selling average. |